Batten Disease Treatment Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Batten Disease Treatment Market: by Type of disease (Juvenile NCL (JNCL), Infantile NCL (INCL), Late infant NCL (LINCL), Adult NCL, Others), Treatment (Gene Therapy, Drug Therapy, Enzyme Therapy, Others), Distribution channel (Hospital Pharmacies, Retail Pharmacies, Others) and Geography (North America, Latin America, Europe, Middle East and Africa, Asia Pacific)

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Batten Disease Treatment Market size is expected to grow at a CAGR of 5.4% during the forecast period 2022 to 2028. The global market provides a detailed overview and which can be segmented by type of disease, treatment, distribution channel, and region. By type of disease, the market has been segmented into juvenile NCL (JNCL), infantile NCL (INCL), late infant NCL (LINCL), adult NCL, and others. By treatment, the adult NCL segment held the largest revenue share of the batten disease treatment market in historic years and is expected to have a significant growth rate over the forecasted period due to the rising adult population suffering from batten disease. By treatment, the has been segmented into gene therapy, drug therapy, enzyme therapy, and others. By treatment, the drug therapy segment held the maximum revenue share of the batten disease treatment market and is anticipated to have a significant growth rate during the forecasted period due to continuous advancement in drug therapy by increasing investment in the healthcare system. By distribution channel, the batten disease treatment market has been segmented into hospital pharmacies, retail pharmacies, and others. By treatment type, the hospital segment held the largest revenue share of the batten disease treatment market in past years and is expected to have the fastest growth rate over the forecasted period due to a high patient population proportion worldwide.

 

Key Development:

In June 2021 – Neurogene Inc., a company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to its adeno-associated virus (AAV) encoding a codon-optimized human CLN5 transgene (hCLN5) for patients diagnosed with CLN5, a subtype of Batten disease.

Batten Disease Treatment Market

MARKET SUMMARY
-
5.4% CAGR
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 5.4%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Batten Disease Treatment Market

  • The report on global batten disease treatment market gives historical, current, and future market sizes (US$ Mn) on the basis of type of disease, treatment, distribution channel and geography.
  • The batten disease treatment market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa
Key Players
  • Abeona Therapeutics Inc. (U.S.)
  • BioMarin Pharmaceutical Inc. (U.S.)
  • CereSpir Inc. (U.S.)
  • Evotec AG (Germany)
  • Ionis Pharmaceuticals Inc. (U.S.)
Batten Disease Treatment Market Drivers

Increase in the incidence of neurological disorders, and also a rise in the investment of biotechnology and pharmaceutical industries in research and development is further expected the growth of the batten disease treatment market. Moreover, the increasing demand for better treatment methods is further estimated to boosting the growth of the batten disease treatment market. Apart from this, the presence of fewer drugs accepted for batten disease is further projected to obstruct the growth of the batten disease treatment market in the timeline period.


North-America got significant share

Batten Disease Treatment Market

North America is expected to have a significant amount of growth in the batten disease treatment market due to an increase in the prevalence rates of batten diseases in many advancing countries of this region. Furthermore, the rise in healthcare facilities is also anticipated to propel the growth of the batten disease treatment market in the region in the coming few years.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about The market size, regional market share and forecast
  • The report covers in-detail insights about The competitor’s overview, key findings and Their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by The industry
  • The report tracks recent innovations, key developments and startup’s details that are working in The industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
Batten Disease Treatment Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The major factors driving the market growth are the rising incidence of neurological disorders, and also a rise in the investment of biotechnology and pharmaceutical industries in research and development, and the launch & adoption of several drugs for the treatment of the batten disease treatment market.

The global batten disease treatment market is expected to grow at a CAGR of 5.4% during the forecast period 2022 to 2028.

Huge investment in healthcare systems and acquisition are the two key strategies opted for by the leading companies in the market.

The Healthcare system is getting huge support from the government around the globe. Cohesive policies and government support improved the healthcare system of the world. For instance, the US spends over $10,000 per individual, which is the highest healthcare spending across the world. Other developed economies such as the UK, Germany, and Canada, among others, inject a significant amount of money into the healthcare system. Even emerging economies including China, Korea, India, Korea, and Thailand are also increasing their healthcare spending.


Report

Table Of Content

  1. Executive Summary
  2. Global Batten Disease Treatment Market Introduction
    • Global Batten Disease Treatment Market – Taxonomy
    • Global Batten Disease Treatment Market –Definitions
      • Type of Disease
      • Treatment
      • Distribution Channel
  1. Global Batten Disease Treatment Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Batten Disease Treatment Market Dynamic Factors – Impact Analysis
    • Global Batten Disease Treatment Market – Competition Landscape
    • Epidemiology
  2. Global Batten Disease Treatment Market Analysis,2015 – 2019 and Forecast, 2020 – 2026
    • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Batten Disease Treatment Market, By Type of Disease, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Juvenile NCL (JNCL)
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Infantile NCL (INCL)
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Late infant NCL (LINCL)
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Adult NCL
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Batten Disease Treatment Market Forecast, By Treatment,2015 – 2019 and Forecast, 2020 – 2026
    • Gene Therapy
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Drug Therapy
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Enzyme Therapy
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Batten Disease Treatment Market Forecast, By Distribution Channel, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Hospital Pharmacies
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail Pharmacies
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Batten Disease Treatment Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Batten Disease Treatment Market – Opportunity Analysis Index, By Type of Disease, By Treatment, By Distribution Channel, and Region, 2020 – 2026
  2. North America Batten Disease Treatment MarketAnalysis,2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Type of Disease Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Juvenile NCL (JNCL)
      • Infantile NCL (INCL)
      • Late infant NCL (LINCL)
      • Adult NCL
      • Others
    • Treatment Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Gene Therapy
      • Drug Therapy
      • Enzyme Therapy
      • Others
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • Country Analysis 2016 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America Batten Disease Treatment Market – Opportunity Analysis Index, By Type of Disease, By Treatment, By Distribution Channel, and Country, 2020 – 2026
    • North America Batten Disease Treatment Market Dynamics – Trends
  3. Europe Batten Disease Treatment Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Type of Disease Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Juvenile NCL (JNCL)
      • Infantile NCL (INCL)
      • Late infant NCL (LINCL)
      • Adult NCL
      • Others
    • Treatment Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Gene Therapy
      • Drug Therapy
      • Enzyme Therapy
      • Others
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Batten Disease Treatment Market – Opportunity Analysis Index, By Type of Disease, By Treatment, By Distribution Channel, and Country, 2020 – 2026
    • Europe Batten Disease Treatment Market Dynamics – Trends
  4. Asia-Pacific Batten Disease Treatment Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Type of Disease Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Juvenile NCL (JNCL)
      • Infantile NCL (INCL)
      • Late infant NCL (LINCL)
      • Adult NCL
      • Others
    • Treatment Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Gene Therapy
      • Drug Therapy
      • Enzyme Therapy
      • Others
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • Country Analysis2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Batten Disease Treatment Market – Opportunity Analysis Index, By Type of Disease, By Treatment, By Distribution Channel, and Country, 2020 – 2026
    • Asia-Pacific Batten Disease Treatment Market Dynamics – Trends
  5. Latin America Batten Disease Treatment Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Type of Disease Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Juvenile NCL (JNCL)
      • Infantile NCL (INCL)
      • Late infant NCL (LINCL)
      • Adult NCL
      • Others
    • Treatment Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Gene Therapy
      • Drug Therapy
      • Enzyme Therapy
      • Others
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Batten Disease Treatment Market – Opportunity Analysis Index, By Type of Disease, By Treatment, By Distribution Channel, and Country, 2020 – 2026
    • Latin America Batten Disease Treatment Market Dynamics – Trends
  6. Middle East and Africa Batten Disease Treatment Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Type of Disease Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Juvenile NCL (JNCL)
      • Infantile NCL (INCL)
      • Late infant NCL (LINCL)
      • Adult NCL
      • Others
    • Treatment Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Gene Therapy
      • Drug Therapy
      • Enzyme Therapy
      • Others
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Others
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Batten Disease Treatment Market – Opportunity Analysis Index, By Type of Disease, By Treatment, By Distribution Channel, and Country, 2020 – 2026
    • MEA Batten Disease Treatment Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Type of Disease& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Abeona Therapeutics Inc. (U.S.)
      • BioMarin Pharmaceutical Inc. (U.S.)
      • CereSpir Inc. (U.S.)
      • Evotec AG (Germany)
      • Ionis Pharmaceuticals Inc. (U.S.)
      • Mitochon Pharmaceuticals Inc. (U.S.)
      • Spark Therapeutics Inc. (U.S.)
  1. Research Methodology
  2. Key Assumptions and Acronyms
  1. Disclaimer
  2. The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.

Report

Company Profile

  • Abeona Therapeutics Inc. (U.S.)
  • BioMarin Pharmaceutical Inc. (U.S.)
  • CereSpir Inc. (U.S.)
  • Evotec AG (Germany)
  • Ionis Pharmaceuticals Inc. (U.S.)
  • Mitochon Pharmaceuticals Inc. (U.S.)
  • Spark Therapeutics Inc. (U.S.)

Description

Batten Disease Treatment Market size is expected to grow at a CAGR of 5.4% during the forecast period 2022 to 2028. The global market provides a detailed overview and which can be segmented by type of disease, treatment, distribution channel, and region. By type of disease, the market has been segmented into juvenile NCL (JNCL), infantile NCL (INCL), late infant NCL (LINCL), adult NCL, and others. By treatment, the adult NCL segment held the largest revenue share of the batten disease treatment market in historic years and is expected to have a significant growth rate over the forecasted period due to the rising adult population suffering from batten disease. By treatment, the has been segmented into gene therapy, drug therapy, enzyme therapy, and others. By treatment, the drug therapy segment held the maximum revenue share of the batten disease treatment market and is anticipated to have a significant growth rate during the forecasted period due to continuous advancement in drug therapy by increasing investment in the healthcare system. By distribution channel, the batten disease treatment market has been segmented into hospital pharmacies, retail pharmacies, and others. By treatment type, the hospital segment held the largest revenue share of the batten disease treatment market in past years and is expected to have the fastest growth rate over the forecasted period due to a high patient population proportion worldwide.

 

Key Development:

In June 2021 – Neurogene Inc., a company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to its adeno-associated virus (AAV) encoding a codon-optimized human CLN5 transgene (hCLN5) for patients diagnosed with CLN5, a subtype of Batten disease.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX